Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
$47.17
-1.7%
$43.54
$33.78
$69.56
$51.89M1.6311,531 shs2,149 shs
BIS
ProShares UltraShort Nasdaq Biotechnology
$17.28
+1.5%
$19.32
$14.05
$25.87
$2.94M-1.4111,953 shs12,656 shs
Loncar China Biopharma ETF stock logo
CHNA
Loncar China Biopharma ETF
$13.53
$13.95
$13.35
$22.89
$10.56M0.95538 shs9 shs
FTXH
First Trust Nasdaq Pharmaceuticals ETF
$26.10
-1.1%
$25.13
$23.29
$29.72
$14.36M0.75,739 shs1,740 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
-1.71%+0.90%+18.40%-11.29%-21.00%
BIS
ProShares UltraShort Nasdaq Biotechnology
+1.53%-1.65%-16.88%+0.64%+2.98%
Loncar China Biopharma ETF stock logo
CHNA
Loncar China Biopharma ETF
0.00%0.00%0.00%0.00%0.00%
FTXH
First Trust Nasdaq Pharmaceuticals ETF
-1.10%+0.65%+7.63%-6.69%-3.97%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/AN/AN/AN/AN/AN/AN/AN/A
BIS
ProShares UltraShort Nasdaq Biotechnology
N/AN/AN/AN/AN/AN/AN/AN/A
Loncar China Biopharma ETF stock logo
CHNA
Loncar China Biopharma ETF
N/AN/AN/AN/AN/AN/AN/AN/A
FTXH
First Trust Nasdaq Pharmaceuticals ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
2.75
Moderate Buy$47.17N/A
BIS
ProShares UltraShort Nasdaq Biotechnology
0.00
N/AN/AN/A
Loncar China Biopharma ETF stock logo
CHNA
Loncar China Biopharma ETF
0.00
N/AN/AN/A
FTXH
First Trust Nasdaq Pharmaceuticals ETF
2.59
Moderate Buy$26.10N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/AN/AN/AN/AN/AN/A
BIS
ProShares UltraShort Nasdaq Biotechnology
N/AN/AN/AN/AN/AN/A
Loncar China Biopharma ETF stock logo
CHNA
Loncar China Biopharma ETF
N/AN/AN/AN/AN/AN/A
FTXH
First Trust Nasdaq Pharmaceuticals ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/AN/A20.68N/AN/AN/AN/AN/A
BIS
ProShares UltraShort Nasdaq Biotechnology
N/AN/A0.00N/AN/AN/AN/AN/A
Loncar China Biopharma ETF stock logo
CHNA
Loncar China Biopharma ETF
N/AN/A0.00N/AN/AN/AN/AN/A
FTXH
First Trust Nasdaq Pharmaceuticals ETF
N/AN/A16.72N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
$0.941.99%N/AN/AN/A
BIS
ProShares UltraShort Nasdaq Biotechnology
$0.653.76%N/AN/AN/A
Loncar China Biopharma ETF stock logo
CHNA
Loncar China Biopharma ETF
$0.060.44%N/AN/AN/A
FTXH
First Trust Nasdaq Pharmaceuticals ETF
$0.481.84%N/AN/AN/A

Latest CHNA, BIS, FTXH, and BIB Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/25/2025
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
Quarterly$0.13091.03%3/26/20253/26/20254/1/2025
3/25/2025
BIS
ProShares UltraShort Nasdaq Biotechnology
Quarterly$0.13252.99%3/26/20253/26/20254/1/2025
3/26/2025
FTXH
First Trust Nasdaq Pharmaceuticals ETF
Quarterly$0.09921.45%3/27/20253/27/20253/31/2025
(Data available from 1/1/2013 forward)
CompanyEmployeesShares OutstandingFree FloatOptionable
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/A1.10 millionN/AOptionable
BIS
ProShares UltraShort Nasdaq Biotechnology
N/A170,000N/AOptionable
Loncar China Biopharma ETF stock logo
CHNA
Loncar China Biopharma ETF
147,000780,814N/ANot Optionable
FTXH
First Trust Nasdaq Pharmaceuticals ETF
147,000550,000N/AOptionable

New MarketBeat Followers Over Time

Media Sentiment Over Time

ProShares Ultra Nasdaq Biotechnology stock logo

ProShares Ultra Nasdaq Biotechnology NASDAQ:BIB

$47.17 -0.82 (-1.71%)
Closing price 06/13/2025 03:55 PM Eastern
Extended Trading
$46.48 -0.69 (-1.47%)
As of 06/13/2025 05:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

ProShares UltraShort Nasdaq Biotechnology NASDAQ:BIS

$17.29 +0.27 (+1.59%)
As of 06/13/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

Loncar China Biopharma ETF stock logo

Loncar China Biopharma ETF NASDAQ:CHNA

The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.

First Trust Nasdaq Pharmaceuticals ETF NASDAQ:FTXH

$26.10 -0.29 (-1.10%)
Closing price 06/13/2025 03:53 PM Eastern
Extended Trading
$26.10 +0.00 (+0.02%)
As of 06/13/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.